We are live on ! Find out more
GBT

Global Blood Therapeutics, Inc.
GBT

Delisted

GBT was delisted on the 4th of October, 2022.

Back to rankings

201 hedge funds and large institutions have $3.07B invested in Global Blood Therapeutics, Inc. in 2019 Q1 according to their latest regulatory filings, with 31 funds opening new positions, 63 increasing their positions, 75 reducing their positions, and 19 closing their positions.

New
Increased
Maintained
Reduced
Closed

176% more call options, than puts

Call options by funds: $83.1M | Put options by funds: $30.2M

63% more first-time investments, than exits

New positions opened: 31 | Existing positions closed: 19

33% more capital invested

Capital invested by funds: $2.32B → $3.07B (+$755M)

6% more funds holding

Funds holding: 190 → 201 (+11)

0% more funds holding in top 10

Funds holding in top 10: 10 → 10 (0)

16% less repeat investments, than reductions

Existing positions increased: 63 | Existing positions reduced: 75

Holders
201
Holders Change
+11
Holders Change %
+5.79%
% of All Funds
4.35%
Holding in Top 10
10
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.22%
New
31
Increased
63
Reduced
75
Closed
19
Calls
$83.1M
Puts
$30.2M
Net Calls
+$53M
Net Calls Change
-$2.13M

Top Buyers

Rank Fund Capital Flow
1
ACA
Avoro Capital Advisors
New York
+$29.5M
2
T. Rowe Price Associates
T. Rowe Price Associates
Maryland
+$22.7M
3
Bank of America
Bank of America
North Carolina
+$16.5M
4
Vanguard Group
Vanguard Group
Pennsylvania
+$13.5M
5
State Street
State Street
Massachusetts
+$10.3M

Top Sellers

Rank Fund Capital Flow
1
BC
Boxer Capital
California
-$22.1M
2
CCM
Camber Capital Management
Massachusetts
-$22.1M
3
Citigroup
Citigroup
New York
-$10.4M
4
Susquehanna International Group
Susquehanna International Group
Pennsylvania
-$10.2M
5
TA
Teachers Advisors
New York
-$10.1M
Name Holding Trade Value Shares
Change 		Change in
Stake
Rafferty Asset Management
51
Rafferty Asset Management
New York
$5.25M +$4.87M +99,149 New
TCIM
52
TIAA CREF Investment Management
New York
$4.85M +$76.8K +1,563 +2%
Swiss National Bank
53
Swiss National Bank
Switzerland
$4.79M +$147K +3,000 +3%
CM
54
Castleark Management
Illinois
$4.74M -$72.2K -1,470 -2%
FMBTD
55
First Midwest Bank Trust Division
Illinois
$4.61M -$5.16M -105,094 -55%
NC
56
Nexthera Capital
New York
$4.61M -$6.61M -134,563 -61%
TCM
57
Tekla Capital Management
Massachusetts
$4.55M -$390K -7,936 -8%
ACM
58
Asymmetry Capital Management
California
$4.53M -$1.03M -21,023 -20%
California State Teachers Retirement System (CalSTRS)
59
California State Teachers Retirement System (CalSTRS)
California
$4.34M +$182K +3,712 +5%
SFM
60
Sphera Funds Management
Israel
$4.23M -$3.29M -67,000 -46%
AllianceBernstein
61
AllianceBernstein
Tennessee
$3.93M +$44.2K +900 +1%
SSA
62
Schonfeld Strategic Advisors
New York
$3.86M +$3.59M +73,000 New
RhumbLine Advisers
63
RhumbLine Advisers
Massachusetts
$3.73M +$199K +4,048 +6%
NIP
64
Nicholas Investment Partners
California
$3.67M +$2.93M +59,581 +608%
State of Wisconsin Investment Board
65
State of Wisconsin Investment Board
Wisconsin
$3.67M +$885K +18,000 +35%
CI
66
Cowen Inc
New York
$3.6M -$491K -10,000 -13%
TD Asset Management
67
TD Asset Management
Ontario, Canada
$3.47M +$167K +3,400 +5%
USAA
68
United Services Automobile Association
Texas
$3.4M – – –
B
69
Bailard
California
$3.38M +$442K +9,000 +16%
PI
70
Putnam Investments
Massachusetts
$3.24M – – –
New York State Common Retirement Fund
71
New York State Common Retirement Fund
New York
$3.23M +$588K +11,968 +24%
GC
72
Guggenheim Capital
Illinois
$3.08M -$264K -5,363 -8%
Neuberger Berman Group
73
Neuberger Berman Group
New York
$2.73M +$786K +16,000 +45%
California Public Employees Retirement System
74
California Public Employees Retirement System
California
$2.53M -$34.4K -700 -1%
American Century Companies
75
American Century Companies
Missouri
$2.5M -$431K -8,762 -16%
1 2
3
4 5

GBT Hedge Fund Activity: Q1 2019 in Review

201 of the 4,620 institutional investors tracked by Wall St. Rank reported a position in Global Blood Therapeutics, Inc. (GBT) for Q1 2019, worth a combined $3.07B — up 33% from $2.32B a quarter earlier.

Buyers outnumbered sellers: 31 funds opened new GBT positions and 19 closed out — a net gain of 12 holders — while 63 added to existing stakes and 75 trimmed.

The largest buyer was Avoro Capital Advisors, adding an estimated $29.5M. The largest seller was Boxer Capital, cutting an estimated $22.1M.

  • 201 institutional investors held Global Blood Therapeutics, Inc. (GBT) as of Q1 2019, up from 190 in Q4 2018.
  • Funds reported $3.07B of Global Blood Therapeutics, Inc. stock for Q1 2019, up 33% quarter-over-quarter.
  • 31 funds opened new Global Blood Therapeutics, Inc. positions in Q1 2019 and 19 closed out, a net change of +12 holders.
  • The largest Global Blood Therapeutics, Inc. buyer in Q1 2019 was Avoro Capital Advisors, an estimated $29.5M added.
  • The largest Global Blood Therapeutics, Inc. seller in Q1 2019 was Boxer Capital, an estimated $22.1M sold.

Based on aggregated 13F filings for Q1 2019.